In 2023 Mölnlycke was awarded a gold medal for Sustainability by EcoVadis
The world’s largest and most trusted provider of business sustainability ratings - EcoVadis, has awarded Mölnlycke a gold medal for our focus on sustainability. They have ranked us in the top 3% of companies worldwide.
The benchmarking procedure
Mölnlycke are in the second year of working with EcoVadis as an independent and credible organisation to benchmark strengths and improvement opportunities. The rating process required extensive amounts of data and documentation, and therefore teamwork between global sustainability, legal and compliance, information technology, procurement excellence, and people experience teams. Our submission was assessed over a four week period. As a continuation from the previous assessment, results and feedback will be used to prioritise improvement plans.
The result
A gold medal is awarded to the all top 5%, and our score puts us into the top 3% of all organisations from all industries worldwide. Particularly recognized during the submission were Mölnlycke's commitment to Science Based Targets and measurable improvements in emissions, the strength of Mölnlycke procedures relating to human rights, demonstrable progress in gender equality, and the availability of the Ethics Hotline to all Mölnlycke's stakeholders
The results certificate is available to download for verification below, EcoVadis will also provide a detailed validated scorecard to users of their platform.
Download our gold medal certificate from EcoVadis
Latest news
-
Mölnlycke Health Care makes record investment to increase global manufacturing capacity with expansion in Maine, USA
Gothenburg, Sweden, 26 June 2025. Mölnlycke Health Care, a global leader in MedTech, today announces its largest investment to date: a €115 million expansion of its wound care manufacturing capacity in Brunswick, Maine, USA.
-
Mölnlycke Health Care secures USD 400 Million in financing from SEK to support global expansion strategy
Stockholm/Gothenburg – 24 June, 2025. Mölnlycke Health Care and The Swedish Export Credit Corporation (SEK) have signed a USD 400 million financing agreement to support the healthcare company’s continued global growth and development.
-
Mölnlycke advocates a holistic approach to healthcare sustainability
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.
-
Mölnlycke Health Care unveils new headquarters at GoCo Health Innovation City, marking a new era of collaboration and innovation
-
Tamer Mölnlycke Care celebrates a new chapter in healthcare in the Kingdom of Saudi Arabia
-
Filippa Stenberg joins Mölnlycke Board of Directors
-
Mölnlycke Health Care inaugurates new global headquarters at GoCo Health Innovation City
Gothenburg, Sweden. 21 May 2025 – Mölnlycke Health Care, a global leader in MedTech, has officially opened its new global headquarters at GoCo Health Innovation City in Gothenburg, Sweden—a major milestone in its journey to drive sustainable healthcare innovation.
-
Mölnlycke Health Care’s long-term target to reach net zero emissions validated by Science Based Targets initiative
Gothenburg, Sweden. 13 May, 2025. Mölnlycke’s long-term net zero greenhouse gas (GHG) emission reduction targets have been validated by the Science Based Targets initiative (SBTi), following prior validation of the company’s near-term GHG emission reduction targets.
-
Mölnlycke Health Care supports the Wound Care Collaborative Community initiative to improve wound dressing standards
Gothenburg, Sweden. May 02, 2025. The Wound Care Collaborative Community (WCCC) is leading a groundbreaking initiative looking to develop a standardised pre-clinical testing framework for wound dressings.